chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Symptoms of full-body chills; swelling of lymph nodes; headache; nausea; This is a spontaneous report from a contactable consumer (patient). A 56-year-old non-pregnant female patient received second dose of BNT162B2 ((PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number not reported) (non-pregnant at the time of vaccination) via intramuscular route of administration on 23Feb2021 15:15 in arm left as single dose for COVID-19 immunisation. The patient was not received any other vaccines within 4 weeks prior to the COVID vaccine. Medical history included hypertension. Concomitant medication included escitalopram, alprazolam, amlodipine taken for an unspecified indication. Historical vaccine included first dose of BNT162B2 on 03Feb2021 in the right arm at single dose for COVID-19 immunisation. No COVID prior vaccination. The patient was not tested for COVID post vaccination. On 24Feb2021 04:00, the patient experienced full-body chills, swelling of lymph nodes, headache and nausea. Outcome of the events were not recovered.  Follow-up attempts are completed. No further information was expected.
Sore arm; couldn't eat anything; Very bad headaches; 102 °F fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), FEEDING DISORDER (couldn't eat anything), HEADACHE (Very bad headaches) and PYREXIA (102 °F fever) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), FEEDING DISORDER (couldn't eat anything), HEADACHE (Very bad headaches) and PYREXIA (102 °F fever). At the time of the report, PAIN IN EXTREMITY (Sore arm), FEEDING DISORDER (couldn't eat anything), HEADACHE (Very bad headaches) and PYREXIA (102 °F fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information was not provided by the reporter.  Treatment information was not provided.
Approximately 10 minutes after vaccine flushing, coughing, wheezing. Respiratory distress and agitation developed. BENADRYL, XOPENEX and EPIPEN Jr. given. Transported by EMS to ER. Treated and recovered.
TRUMENBA given in error instead of PREVNAR 13 on 4-19-17. Dr consulted infectious disease MD Dr. on 4/19/17. Fever started 4-19-17, vomited 4-5x 4/21/17 with fatigue, irritability. All signs and symptoms resolved 4/22/17.
Pt was observed post vaccination complaining of dizziness & light headedness, pt brought to triage and attended by the doctor. Ekg was normal, pt sitting on gurney with pt's husband at bedside, EMS was also at bedside, pt was initially hypertensive, the rest of the vitals were normal, pt was give orange and apple juice, tolerated, observed further, vitals improved, pt denies any complaints and discharged. Pt wheeled off unit by nurse.
Mom came in to have TB skin test read & stated that pt slept for four hrs p/vax & when pt woke up was hot to touch & limp; taken to hosp t104-stated ER MD said pt was probably having a rxn to DTP & to give APAP;
I got really feverish, bad headache,extremly exhausted for few days.Since second dose I have exp headaches off and on.
little bit of arm pain; stiff neck pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (little bit of arm pain) and MUSCULOSKELETAL STIFFNESS (stiff neck pain) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included HYDROCHLOROTHIAZIDE and THYROID (ARMOUR THYROID) for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (little bit of arm pain) and MUSCULOSKELETAL STIFFNESS (stiff neck pain). At the time of the report, PAIN IN EXTREMITY (little bit of arm pain) and MUSCULOSKELETAL STIFFNESS (stiff neck pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Treatment medications are Reported.
Soreness at injection site & unable to lift right arm to the side without tightness and pain
This case was reported by a nurse and described a 58-year-old female subject who did not respond to immunization to the Engerix-B series. The subject's medical history included diabetes and smoker. Concurrent medications included Venlafaxine hydrochloride (Effexor), Carvedilol (Coreg), Simvastatin (Zocor), Metformin hydrochloride (Metformin), Human Insulin (Lantus), Oestradiol (Estradiol) and Diltiazem hydrochloride (Diltiazem xr). On 12 December 2005 the subject received 3rd dose of Engerix-B. On 17 February 2006, 67 days after vaccination with Engerix-B, a hepatitis B surface antibody titer was low at 3 mUI/ml.
My wife and I both contracted, we both had all the Pfizer boosters (Unspecified booster), everything else, booster twice, we both ended up with COVID; My wife and I both contracted, we both had all the Pfizer boosters (Unspecified booster), everything else, booster twice, we both ended up with COVID; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received BNT162b2 (BNT162B2), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "My wife and I both contracted, we both had all the Pfizer boosters (Unspecified booster), everything else, booster twice, we both ended up with COVID". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: The reporter stated he and his wife both contracted, they both had all the Pfizer boosters (Unspecified booster) and everything else, booster twice and both ended up with COVID 2 days ago and one of the friend told they should try Paxlovid. But the reporter went to hospital, and they said his vitals were fine just go home and let the go, but they ended up taking one dose, that was the major side effects of diarrhea and loss of appetite. So, reporter think they should stop taking it.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Gave patient Tdap and varicella in R arm and Meningococcal and HPV in left arm. About one minute after shots give, patient fainted.
Patient received the Pfizer COVID19 vaccine for her first dose and inadvertently received the Moderna COVID19 vaccine for her second dose.
First shot I got a large red circle around the injection sight. It got hard. It hurt. But it went away in a week. It also got itchy.; First shot I got a large red circle around the injection sight. It got hard. It hurt. But it went away in a week. It also got itchy.; First shot I got a large red circle around the injection sight. It got hard. It hurt. But it went away in a week. It also got itchy.; This is a spontaneous report from a contactable consumer (patient). A 42-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: ER8727) via an unspecified route of administration, administered in arm left on 20Mar2021 at 14:30 (at the age of 42-year-old) as dose 1, single for COVID-19 immunisation. Medical history included irritable bowel syndrome, endometriosis, hypothyroid all from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the covid vaccine. The patient had no allergies to medications, food, or other products. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient was not tested for COVID-19. Concomitant medications received within 2 weeks of vaccination included as prescribed and OTC. On unknown date in 2021 the patient experienced a large red circle around the injection sight, it got hard, it hurt but it went away in a week. it also got itchy. The events were reported as non-serious. The patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, lot number=EP7533) via an unspecified route of administration, administered in arm right on 10Apr2021 at 14:45 as dose 2, single for COVID-19 immunisation. Outcome of the event vaccination site pruritus was unknown and for other events was resolved on unknown date in 2021.  No follow up attempts are needed. No further information expected.
Transverse Myelitis/ Guillan Barre Syndrome,  Full paraplagia LEs.  Fecal/urinary incontinence.
pt recv vax & that evening pt exp a gen h/a;9JUL96 pt exp diarrhea, & urinated every 20min for 7hr;later that same evening pt exp chills;10JUL96 pt exp aches, joint pain, fever 102;dizziness & vomiting;11JUL96 exp upset stomach;weakness
pt recv vax 4FEB97 & pt was unable to take a breath p/crying;pt was @ first cyanotic but color returned p/getting first breath;pt hyporesponsive x 5min;pt did not completely pass out;
Almost immediately after the patient received the immunization at 11:15 AM, his mother noticed that he had a rash on his arm and abdomen, around 11:20 AM.  I assessed the patient and he was noted to have 3 small "hives" on his left arm which were below the injection site. He also has 3 small "hives" to the right side of his umbilicus. Pt C/O itching but also stated, "he always itches".  His mother had 2- 12.5 mg Benadryl  tablets in which I instructed her to give the first tablet immediately at 11:20 AM.  I listened to patient's breath sounds, which were clear and equal to all fields.  Pt denied any numbness or tingling, or difficulty breathing.  His airway was open and tongue was not swollen.  I remained with patient for 40 minutes and no changes were noted. His mom did give him another dose of 12.5 mg Benadryl at 11:40 AM and she notified her patient's allergist.  No other orders were needed and pt went home with his mother.
I had the Zostavax shingles vaccination at age 60 in June of 2012 because my husband had had a horrible case of shingles before his death, and I didn?t want to end up going through that ordeal too.  I was so relieved to get it.  I had no side effects or issues with it.    Then fast forward to 2021 when all you heard on commercials and in pharmacies was to ?Get the new Shingrix shingles vaccinations (two injections, 60 days apart) because they?re much more effective than Zostavax?.  I felt very uneasy about it, especially after also hearing the ongoing hard push for covid-19 ?vaccinations? that I did not want and refused to get.   When I took my 90-year-old mother to pick up some of her end-of-the-year prescription refills at pharmacy on December 29, 2021, she noticed their shingles vaccination posters plastered everywhere and after consulting with the pharmacist on duty that day, decided on the spur of the moment to get her first Shingrix injection while we were there. Regrettably, I ended up going against my gut instincts and got one too.    The next month was absolute hell. I have never been so sick in my life, and my frail, elderly mother went through the same experience.  A bad batch of vaccine serum?  I don?t know. But we both had extremely severe headaches, fevers, nausea, vertigo, injection site soreness to the point of not being able to lift our arms, weird delirious dreams, exhaustion, generalized muscle aches, shingles-type skin problems, but with fine filaments eventually emerging from the skin.  We felt too sick to even get out of bed other than to make it to the bathroom when necessary and to try to eat a little.  It felt like we were dying.  The reactions slowly subsided after about a month, but to this day, we both have shingles-type flareups occasionally.  Neither of us had had bad cases of chicken pox during childhood, only very light cases.    When we were due for our second Shingrix injections, the pharmacy hounded us both with constant phone calls and text messages to come in and get the second shot, even after we both repeatedly said NO WAY and requested no further followup contact.  They were so persistent about it that I?ve often wondered if huge kickbacks for meeting compliance goals from the pharmaceutical industry to pharmacies, doctors, nurses, and medical facilities was the reason for the frantic push for these vaccinations.
Pt is 39 yo female, s/p full Pfizer COVID vaccination: dose 1 on 1/25 and dose 2 on 2/15. Pt is an employee at this institution. Reports new onset cough, fatigue, headache, loss of taste/smell, congestion/runny nose. Denies any known exposure to a COVID positive person. Receives casirivimab/imdevimab infusion on 8/9.
Patient's mother misinformed us about patient's age. Listed on form as incorrect DOB when actual birthday is exact date. Mother verbally confirmed the incorrect birthday several times during the visit. Issue was discovered at the time of billing when the insurance informed us of the exact date birthday. When we called the mother back to confirm which is correct, she admitted to putting the wrong birthdate on the form. We informed her that the patient cannot get a follow up immunization until after the actual date of birth.
diagnosed with COVID-19; diagnosed with COVID-19; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient's son) reported that a female patient (mother) of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot and expiry were not reported), via an unspecified route of administration on 27Mar2021 as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The consumer (patient's son) called behalf of his mother (patient) who had the first shot last 27Mar2021 and then in 2021 diagnosed with COVID-19 as well and also now negative with the virus. The patient was given bamlanivimab and took it 5 days ago. The patient was scheduled today for the second shot of COVID-19 Vaccine. The consumer's main concern was to know if the vaccine was safe to take after all. The outcome of the event was recovered in 2021.  Information on the lot/batch number has been requested.
Information has been received from a physician concerning a 2 year old female who in approximately August 2003, was vaccinated with a dose of varicella virus vaccine live. In approximately August 2004, the patient developed what the physician believed to be shingles. It was reported that the patient was seen a few days later by another establishment and was diagnosed with folliculitis. The patient was treated with antibiotics. Subsequently, the patient recovered. It was noted that her older brother had not been vaccinated, but had wild chickenpox and developed shingles. There was no product quality complaint. Additional information is not expected.
inflammation at injection site; bumpy, itchy rash/ a reddish, irregular, raised hive-like appearance; bumpy, itchy rash/ a reddish, irregular, raised hive-like appearance; Chills; Shakes; experienced redness and warmth at the injection site.; experienced redness and warmth at the injection site.; This case was reported by a nurse via call center representative and described the occurrence of injection site erythema in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 2nd July 2021, the patient received the 1st dose of Shingrix. On 2nd July 2021, less than a day after receiving Shingrix, the patient experienced injection site erythema, injection site warmth, chills and tremor. On 5th July 2021, the patient experienced erythropapular rash and hives. On an unknown date, the patient experienced injection site inflammation. On 13th July 2021, the outcome of the erythropapular rash and hives were recovered/resolved. On an unknown date, the outcome of the injection site erythema, injection site warmth, injection site inflammation, chills and tremor were recovered/resolved.   It was unknown if the reporter considered the injection site erythema, injection site warmth, injection site inflammation, chills, tremor, erythropapular rash and hives to be related to Shingrix.  Additional information was provided as follows: The patient experienced redness and warmth at the injection site and chills, shakes that night, on the day dose was received.  On an unknown date, less than a week after vaccination the patient also had inflammation at injection site. On 5th July 2021, 3 days after vaccination the patient developed a bumpy, itchy rash which was along lower abdomen and upper breasts and had a reddish, irregular, raised hive-like appearance with visible border.  Till the time of reporting the patient had not received second dose of Shingrix. The reporter consented to follow up.
Rash. Swelling. Fever. Dizzying.  Vomiting.
10min after Fluzone she started with cough, went into respiratory distress shortly, ped called.  911 called and taken to ER.  I gave Benadryl, albuterol neb given in ambulance, PO steroids in ER. Also with mild hives and facial swelling in ER.
"Received 2nd Covid vaccination have had headaches, earaches, tachycardia, and SOB since vaccination"  TM was hospitalized 3xs after vaccination. On 1/24/21 TM was hospitalized and kept overnight for tachycardia and SOB and has to f/u with cardiology this week.  The second time TM went to the hospital for a headache where an MRI was done. The third time she was also treated for a headache
19APR93 low grade fever, lt arm hot, swollen, red spot; approx 2-2 1/2" knot; c/o arm hurting;
This is just for statistical information. This baby developed intussusception 7/4/07 at 6 months of age. He had two doses of Rotateq at 2 and 4 months of age (with other shots). He had not received the third dose.  8/10/07 Received pcp medical records including vax records which confirm RO dose & lot # as reported.  Records reveal patient experienced good development & was healthy on day of vax.  Seen in ER on 7/4 s/p vomiting & bloody stools.  CT confirmed IS.  BE could not reduce & had surgery.  Returned to office on 7/30 for post op check & doing well.  8/24/07 Received hospital medical records which reveal patient experienced nonbilious emesis, abdominal pain & distention, low grade fever & jelly like stool x 2 days.  Admitted 7/5-7/6/07.  Air enema x 3 unable to reduce IS.  Taken to OR for laproscopic reduction of IS.  Progressed well & d/c to home. FINAL DX: Ileocolic intussusception, surgically reduced.
7 days after I received the first dose, my arm swelled, red spot the size of a baseball and very itchy with whelps.  Up until this point I had no side effects.
Light headed dizzy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Light headed dizzy) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Light headed dizzy). At the time of the report, DIZZINESS (Light headed dizzy) outcome was unknown.            No concomitant medications were mentioned. No treatment details were reported.
102-103 fever w/severe swelling & redness @ inj site;given advil & motrin;sick for several days; MD said probably a virus;given tepid baths;would not eat or drunk;
Pt reports swelling, redness, pain, rash in left arm where shot was given. This happened within a day of her vaccination. She was advised by a physician to take a pain reliever which she said offered no relief.
Rt arm edematous fr infect site to 5in below elbow; arm warm to touch & red;
Patient was administered prior to age verification.  Janssen vaccine is not indicated for this patients <18.  Pharmacy didnt realize this until entering medication into EHR and the alert send the reminder.
METALLIC TASTE ALL AROUND MOUTH MORE ON ONE SIDE THAN THE OTHER; MASSIVE COLD SORE OUTBREAK AROUND WHOLE MOUTH; HARD TIME SWALLOWING FOR A DAY AND A HALF OR TWO; SEVERE JOINT PAIN THAT SEEMS TO BE SPREADING THROUGH BODY; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported.  The patient's concurrent conditions included: cold sore outbreak. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 01-SEP-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On SEP-2021, the patient experienced massive cold sore outbreak around whole mouth. On SEP-2021, the patient experienced hard time swallowing for a day and a half or two. On SEP-2021, the patient experienced severe joint pain that seems to be spreading through body. On 01-SEP-2021, the patient experienced metallic taste all around mouth more on one side than the other. The action taken with covid-19 vaccine was not applicable. The patient recovered from hard time swallowing for a day and a half or two on SEP-2021, had not recovered from massive cold sore outbreak around whole mouth, and severe joint pain that seems to be spreading through body, and the outcome of metallic taste all around mouth more on one side than the other was not reported. This report was non-serious.
fatigue starting about 1500 on 29 Dec 2020 until bed at 2100hrs. Injection site pain/tenderness and hot to the touch. slight fever and chills. joint pain in knees (more than usual)
This spontaneous report as received from a female patient of unknown age concerning herself. The patient's concurrent conditions, medical histories and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with a dose of PNEUMOVAX 23 (lot #, expiration date and dose were unknown), intramuscularly for immunization against pneumococcal disease. On an unknown date, the patient experienced itchiness, swelling and redness at the injection site. The outcome of the events was reported as recovering. There was no reintroduced (also reported as "therapy with PNEUMOVAX 23 was continued"). The patient stated that she would address the matter through other means. No product quality complaint (PQC) was reported. The reporter did not assess the causality. Additional information has been requested.
Patient with multimyeloma, B-cell lymphocytic leukemia, with pancytopenia requiring frequent transfusions admitted with weakness above baseline. Patient was found to have moderate bacturia on urinalysis and was treated with Rocephin.  In addition, patient had severe thrombocytopenia with a platelet count of 6000.  She was given 1 unit of platelets.  She was started on prednisone 20 mg twice daily with improvement in her platelets. Discharged to nursing home. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
Patient experienced swollen lymph node the size of a jelly bean.  will seek treatment from PCP
I developed on my left upper arm where the vaccine was applied a hard lump, the skin is red,  it?s burning/hot,  and itches.